Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria de la Fuente

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Investigative Ophthalmology & Visual Science|April 26, 2008
Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapyMaria de la Fuente, Begoña Seijo, Maria J Alonso
Research and Practice in Thrombosis and Haemostasis|February 4, 2021
Complement factor C4a does not activate protease-activated receptor 1 (PAR1) or PAR4 on human plateletsXu Han, Maria de la Fuente, Marvin T Nieman
Biochemistry|January 21, 2020
Expression and Purification of Protease-Activated Receptor 4 (PAR4) and Analysis with Histidine Hydrogen-Deuterium ExchangeMaria de la Fuente, Xu Han, Masaru Miyagi, et al.
Nature Communications|July 4, 2015
Increased reservoir ages and poorly ventilated deep waters inferred in the glacial Eastern Equatorial PacificMaria de la Fuente, Luke Skinner, Eva Calvo, et al.
Nanomedicine (London, England)|November 26, 2008
Nanoparticles as protein and gene carriers to mucosal surfacesMaria de la Fuente, Noémi Csaba, Marcos Garcia-Fuentes, et al.
The Journal of Gene Medicine|November 30, 2007
Low molecular weight hyaluronan shielding of DNA/PEI polyplexes facilitates CD44 receptor mediated uptake in human corneal epithelial cellsMargit Hornof, Maria de la Fuente, Marjut Hallikainen, et al.
Analytical Biochemistry|April 9, 2013
Functional characterization of heat shock protein 90 targeted compoundsIsa N Cruz, Yixi Zhang, Maria de la Fuente, et al.
Expert Opinion on Drug Delivery|March 18, 2009
Chitosan nanoparticles for drug delivery to the eyePatrizia Paolicelli, Maria de la Fuente, Alejandro Sánchez, et al.
Cureus|August 11, 2022
Potential of Plasma Rich in Growth Factors (PRGF-Endoret) to Enhance the Efficacy of Assisted Reproductive Techniques in Refractory CasesJon Ander Agirregoikoa, Jose Luis de Pablo, Maria de la Fuente, et al.
Blood|June 24, 2020
PAR4 activation involves extracellular loop 3 and transmembrane residue Thr153Xu Han, Lukas Hofmann, Maria de la Fuente, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Investigative Ophthalmology & Visual Science|April 26, 2008
Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapyMaria de la Fuente, Begoña Seijo, Maria J Alonso
Research and Practice in Thrombosis and Haemostasis|February 4, 2021
Complement factor C4a does not activate protease-activated receptor 1 (PAR1) or PAR4 on human plateletsXu Han, Maria de la Fuente, Marvin T Nieman
Biochemistry|January 21, 2020
Expression and Purification of Protease-Activated Receptor 4 (PAR4) and Analysis with Histidine Hydrogen-Deuterium ExchangeMaria de la Fuente, Xu Han, Masaru Miyagi, et al.
Nature Communications|July 4, 2015
Increased reservoir ages and poorly ventilated deep waters inferred in the glacial Eastern Equatorial PacificMaria de la Fuente, Luke Skinner, Eva Calvo, et al.
Nanomedicine (London, England)|November 26, 2008
Nanoparticles as protein and gene carriers to mucosal surfacesMaria de la Fuente, Noémi Csaba, Marcos Garcia-Fuentes, et al.
The Journal of Gene Medicine|November 30, 2007
Low molecular weight hyaluronan shielding of DNA/PEI polyplexes facilitates CD44 receptor mediated uptake in human corneal epithelial cellsMargit Hornof, Maria de la Fuente, Marjut Hallikainen, et al.
Analytical Biochemistry|April 9, 2013
Functional characterization of heat shock protein 90 targeted compoundsIsa N Cruz, Yixi Zhang, Maria de la Fuente, et al.
Expert Opinion on Drug Delivery|March 18, 2009
Chitosan nanoparticles for drug delivery to the eyePatrizia Paolicelli, Maria de la Fuente, Alejandro Sánchez, et al.
Cureus|August 11, 2022
Potential of Plasma Rich in Growth Factors (PRGF-Endoret) to Enhance the Efficacy of Assisted Reproductive Techniques in Refractory CasesJon Ander Agirregoikoa, Jose Luis de Pablo, Maria de la Fuente, et al.
Blood|June 24, 2020
PAR4 activation involves extracellular loop 3 and transmembrane residue Thr153Xu Han, Lukas Hofmann, Maria de la Fuente, et al.
Pageof 5